Structure Therapeutics (GPCR) Tax Provisions (2022 - 2026)
Structure Therapeutics' (GPCR) quarterly Tax Provisions came in at $190000.0 in Q1 2026, up 93.88% year-on-year from $98000.0 in Q1 2025, and up 135.71% quarter-over-quarter from -$532000.0 in Q4 2025.
Structure Therapeutics (GPCR) Tax Provisions (2022 - 2026) Analysis & Trends
Structure Therapeutics' Tax Provisions history runs 5 years deep, the most recent figure standing at $190000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions rose 93.88% year-over-year to $190000.0 in Q1 2026; TTM through Mar 2026 was -$95000.0, a 123.93% decrease from a year earlier, with the FY2025 full-year figure at -$187000.0, down 157.01% from the prior year.
- Tax Provisions climbed to $190000.0 in Q1 2026 per GPCR's latest filing, from -$532000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $405000.0 in Q3 2023 and bottomed at -$616000.0 in Q4 2023.
- The 5-year median for Tax Provisions is $73000.0 (2022), against an average of $20000.0.
- Across the five-year window, Tax Provisions jumped 454.79% in 2023 and plunged 445.45% in 2025, its largest moves.
- Year by year, Tax Provisions stood at -$120000.0 in 2022, then sank by 413.33% to -$616000.0 in 2023, then jumped by 125.0% to $154000.0 in 2024, then plunged by 445.45% to -$532000.0 in 2025, then soared by 135.71% to $190000.0 in 2026.
- Per Business Quant, the three latest GPCR Tax Provisions figures stand at $190000.0 (Q1 2026), -$532000.0 (Q4 2025), and $108000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Structure Therapeutics | 11.04 Bn | 11.04 Bn | - | 190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | -532,000.00 |
| Sep 30, 2025 | 108,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | -616,000.00 |
| Sep 30, 2023 | 405,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | -120,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | 60,000.00 |